Updates are available Correction dated 2020-03-07
Click to view Correction: https://doi.org/10.1038/s41586-020-2064-8
-
Authors
Luteijn, Rutger D.
Zaver, Shivam A.
Gowen, Benjamin G.
Wyman, Stacia K.
Garelis, Nick E.
Onia, Liberty
McWhirter, Sarah M.
Katibah, George E.
Corn, Jacob E.
Woodward, Joshua J.
Raulet, David H.
- License Information
-
More Information
Article History
Received: 21 November 2018
Accepted: 8 August 2019
First Online: 11 September 2019
Change Date: 7 March 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: D.H.R. is a co-founder of Dragonfly Therapeutics and served or serves on the scientific advisory boards of Dragonfly, Aduro Biotech, and Ignite Immunotherapy; he has a financial interest in all four companies and could benefit from commercialization of the results of this research. S.M.M. is, and G.E.K. was, an employee of Aduro Biotech.
